• search

TCS with US-based Eli Lilly for advance clinical research

Written by: Staff

New Delhi, Nov 15 (UNI) Tata Consultancy Services (TCS) today said it has formed an agreement with US-based corporation Eli Lilly and Company, engaged in developing pharmaceutical products to advance its clinical research and development in the country.

Under the agreement, TCS has established a new facility, 'Lilly-TCS medical information sciences centre' at its Noida site to house the staff working on Lilly projects.

Through this new centre, TCS will work with Lilly's medical information sciences disciplines to provide a wide range of services in clinical data management, statistical analysis and medical writing.

''The goal of our relationship with TCS has several dimensions beyond reducing cost and risk, including gaining access to a global talent pool, increasing flexibility and scalability of our resources and maintaining a global workflow that is operational 24 hours a day,'' Eli Lilly's Global Medical Information Sciences Group Director Steve Ruberg said.

TCS Life Sciences and Healthcare Executive Vice-President J Rajagopal said the Lilly-TCS project is anticipated to be a role model for the life sciences sector as it is designed to create mutual benefits based on collaboration and increased productivity within the two organisations.


For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more